{
  "meta": {
    "title": "Haem_Catabolism",
    "url": "https://brainandscalpel.vercel.app/haem-catabolism-28a431f7.html",
    "scrapedAt": "2025-11-29T18:23:55.902Z"
  },
  "questions": [
    {
      "id": 7697,
      "choices": [
        {
          "id": 30756,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 BPG is an intermediate of Gluconeogenesis</span></span></span></p>"
        },
        {
          "id": 30757,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right</span></span></span></p>"
        },
        {
          "id": 30758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of 2,3 BPG stabilises the R state</span></span></span></p>"
        },
        {
          "id": 30759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 BPG has increased interaction with HbF</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding the interaction of hemoglobin with 2, 3-BPG</span></span></span></p>",
      "unique_key": "Q9882383",
      "question_audio": null,
      "question_video": null,
      "map_id": 29819,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interaction of Hemoglobin with 2, 3 BPG</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3 BPG</strong> is an <strong>intermediate of Glycolysis</strong> synthesized with the help of <strong>2, 3 BPG Shunt or Rapoport Luebering Cycle. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Hemoglobin tetramer </strong>binds to <strong>one mol of 2,3 BPG</strong> in the central cavity formed by <strong>four subunits.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2,3 BPG</strong> forms <strong>salt bridges</strong> with a<strong> terminal amino group of both &beta; globin chain </strong>via, <strong>Valine, Lysine and Histidine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of <strong>2,3 BPG decreases the affinity of Hb to Oxygen</strong>, by <strong>stabilizing the T state</strong> and shifts the<strong> ODC to right.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3 BPG</strong> has <strong>decreased interaction with HbF</strong> as histidine forms <strong>salt bridges </strong>with <strong>2,3 BPG is not </strong>present in<strong> &gamma; chain of HbF</strong> &rarr;<strong> Instead</strong> of <strong>Histidine</strong> it is <strong>Serine, so 2,3 BPG </strong>has <strong>less interaction </strong>with <strong>Fetal Hb</strong> &rarr; accounts for <strong>high affinity of HbF</strong> towards <strong>Oxygen.</strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture18.jpg\" style=\"height:277px; width:700px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: 2, 3-BPG is an intermediate of gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>incorrect.</strong> <strong>2, 3-BPG </strong>is formed from <strong>1,3-bisphosphoglycerate</strong> during<strong> glycolysis, not gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Binding of 2,3-BPG stabilizes the R state:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect.</strong> <strong>2, 3-BPG </strong>binds to and stabilizes the <strong>T (tense) state of Hb</strong>,<strong> not</strong> the<strong> R (relaxed) state</strong>, which has a <strong>higher affinity for oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3-BPG has increased interaction with HbF:</strong> This is <strong>incorrect</strong>. <strong>HbF</strong> has a <strong>lower affinity for 2, 3-BPG </strong>than <strong>adult hemoglobin</strong> (HbA), which contributes to<strong> its higher affinity for oxygen</strong>, <strong>facilitating oxygen </strong>transfer from the <strong>mother to the fetus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2, 3-BPG</strong> is a <strong>metabolite </strong>in the <strong>glycolytic pathway</strong> that binds to <strong>deoxyhemoglobin</strong> (<strong>Hb</strong> in the<strong> T or tense state)</strong> and <strong>stabilizes it</strong>, which <strong>decreases</strong> the <strong>oxygen affinity of Hb</strong>. This <strong>interaction</strong> is crucial for the <strong>release of O2 in tissues. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of <strong>2, 3-BPG to Hb </strong>thus<strong> facilitates the delivery of oxygen</strong> to tissues by <strong>promoting the release of oxygen </strong>from <strong>Hb</strong>, which is reflected as a <strong>rightward shift in the ODC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 288.</span></strong></span></span></p>",
      "correct_choice_id": 30757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6032,
      "choices": [
        {
          "id": 24098,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjugated bilirubin</span></p>"
        },
        {
          "id": 24099,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconjugated bilirubin</span></p>"
        },
        {
          "id": 24100,
          "text": "<p><span style=\"font-size:12.0pt;\">Urobilinogen</span></p>"
        },
        {
          "id": 24101,
          "text": "<p><span style=\"font-size:12.0pt;\">Bile salts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient with a history of jaundice was subjected to a direct Van den Bergh reaction as part of his diagnostic workup. The test came positive. Based on these results, which type of bilirubin is present in the patient's blood serum that would cause a positive direct Van den Bergh’s reaction?</span></p>",
      "unique_key": "Q8905947",
      "question_audio": null,
      "question_video": null,
      "map_id": 29818,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Conjugated bilirubin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br><span style=\"font-size:12.0pt;\">The <strong>Van den Bergh reaction</strong> is a classic diagnostic test used to differentiate between <strong>conjugated (direct) bilirubin</strong> and <strong>unconjugated (indirect) bilirubin</strong> in serum.</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Conjugated bilirubin</strong> is <strong>water-soluble</strong> because it has been conjugated with glucuronic acid in the liver. It reacts <strong>directly</strong> with <strong>diazotized sulfanilic acid (diazo reagent)</strong> to form a <strong>purple azo dye</strong> — without requiring alcohol. This immediate reaction is called a <strong>Direct Positive Van den Bergh Test</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, a <strong>positive direct reaction</strong> means conjugated bilirubin is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option B — Unconjugated (free) bilirubin:</strong></span><br><span style=\"font-size:12.0pt;\">Incorrect.</span><br><span style=\"font-size:12.0pt;\">Unconjugated bilirubin is <strong>water-insoluble</strong> and does <strong>not react directly</strong> in an aqueous solution with the diazo reagent. It needs to be dissolved in <strong>alcohol</strong> first, and then the test becomes positive. This is called an <strong>indirect reaction</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C — Urobilinogen:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">Urobilinogen is tested with <strong>Ehrlich’s reagent (p-dimethylaminobenzaldehyde)</strong>, not the diazo reagent, and forms a <strong>red color</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D — Bile salts:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">Bile salts are detected by <strong>Hay’s sulfur test</strong>, which relies on surface tension reduction, not a colorimetric diazo reaction.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A <strong>positive direct Van den Bergh reaction</strong> confirms the presence of <strong>conjugated (water-soluble) bilirubin</strong> in serum. Elevated conjugated bilirubin is typically seen in <strong>hepatocellular dysfunction, cholestasis, or bile duct obstruction</strong> — situations where conjugated bilirubin escapes into the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref:&nbsp;DM Vasudevan 9/e: p 369, 370, 398, 399.</span></p>",
      "correct_choice_id": 24098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7678,
      "choices": [
        {
          "id": 30680,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
        },
        {
          "id": 30681,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carboxy hemoglobinemia</span></span></span></p>"
        },
        {
          "id": 30682,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;-Thalassemia</span></span></span></p>"
        },
        {
          "id": 30683,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methemoglobinemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man comes to the clinic with symptoms including a bluish tint to his skin on his face and extremities, shortness of breath, and headaches. His medical history reveals that he has been taking sulfa drugs. Given these clinical features and medication history, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q3664273",
      "question_audio": null,
      "question_video": null,
      "map_id": 29820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methemoglobinemia</span></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemoglobin</strong> containing heme iron&#39;s <strong>ferric (Fe3+)</strong> state is called <strong>methaemoglobin</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methemoglobinemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>abnormal</strong> accumulation of <strong>methaemoglobin.</strong> It can be caused by <strong>genetic abnormalities</strong> <strong>(inherited methemoglobinemia)</strong> or intake of certain drugs &amp; chemicals <strong>(acquired methemoglobinemia)</strong> such as <strong>sulphonamides, aniline</strong> etc.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since <strong>methaemoglobin</strong> has <strong>poor binding capacity with oxygen</strong> results in <strong>bluish discoloration of the skin and mucous</strong> membranes <strong>(cyanosis) </strong>and<strong> </strong>symptoms of<strong> tissue hypoxia</strong> such as <strong>anxiety, headache, dyspnoea, coma and death</strong> can occur. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by<strong> lifelong pain crises,</strong> <strong>chronic hemolytic anemia</strong> with <strong>hyperbilirubinemia</strong> and <strong>increased</strong> susceptibility to <strong>infections</strong>. Other symptoms -<strong> acute chest syndrome, stroke, splenic and renal dysfunction</strong> and <strong>bone changes </strong>due to <strong>marrow hyperplasia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carboxy hemoglobinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Carbon monoxide </strong>binds to <strong>haemoglobin</strong> very <strong>avidly</strong>. The patient presents with <strong>confusion and</strong> symptoms of<strong> O2 deprivation,</strong> but <strong>not dyspnoea,</strong> since the <strong>hemoglobin is fully saturated, </strong>and <strong>lips</strong> have a typical <strong>red colour</strong> as a result of the <strong>hemoglobin getting oxygenated.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;-Thalassemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Characterized by a <strong>decrease or absence of beta chains synthesis</strong> with <strong>compensatory increase</strong> in<strong> gamma or</strong> <strong>delta chains.</strong> They<strong> present</strong> with<strong> hypochromic microcytic anemia </strong>and <strong>ineffective erythropoiesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Methemoglobinemia</strong>, associated with certain medications like <strong>sulfa drugs</strong>, leads to symptoms of <strong>cyanosis and dyspnea </strong>due to an <strong>altered oxygen-carrying state of hemoglobin</strong>. <strong>Sickle cell anemia and &beta;-Thalassemia </strong>present with <strong>different hematological issues</strong>, while <strong>carboxyhemoglobinemia </strong>is typically linked to<strong> carbon monoxide exposure</strong>,<strong> not sulfa drugs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 692-693.</span></span></strong></p>",
      "correct_choice_id": 30683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7680,
      "choices": [
        {
          "id": 30688,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urobilinogen</span></span></span></p>"
        },
        {
          "id": 30689,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugated bilirubin</span></span></span></p>"
        },
        {
          "id": 30690,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unconjugated bilirubin</span></span></span></p>"
        },
        {
          "id": 30691,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemosiderin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents to the clinic for a routine health checkup. As part of his evaluation, a blood test is performed. When his blood sample is treated with Ehrlich&rsquo;s solution, it gives a purplish-brown color. Which of the following substances is most likely present in the patient&#39;s blood to account for this color change?</span></span></span></p>",
      "unique_key": "Q7221832",
      "question_audio": null,
      "question_video": null,
      "map_id": 29816,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urobilinogen</span></strong>&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ehrlich&rsquo;s solution</strong> is a <strong>reagent </strong>used to test for the<strong> presence of urobilinogen</strong> in <strong>urine or blood.</strong> A <strong>positive reaction,</strong> indicated by a <strong>purplish-brown color change</strong>, suggests the <strong>presence of urobilinogen. Urobilinogen</strong> is a <strong>colorless by-product of bilirubin reduction</strong>. It is <strong>formed </strong>in the<strong> intestines</strong> by <strong>bacterial action on bilirubin</strong>, a portion of which is <strong>absorbed</strong> back into the <strong>bloodstream</strong>, <strong>excreted</strong> in the<strong> urine</strong>, or further <strong>converted</strong> into<strong> stercobilin</strong> and <strong>excreted in feces</strong>. The <strong>presence of urobilinogen </strong>in the patient&#39;s blood, indicated by the reaction with<strong> Ehrlich&#39;s reagent</strong>, can be associated with <strong>various liver and hematological disorders</strong>, making it an <strong>important</strong> <strong>diagnostic marker.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Conjugated bilirubin&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- This is<strong> water-soluble</strong> and would<strong> not react to Ehrlich&rsquo;s solution</strong> in the same manner as <strong>urobilinogen.</strong> It is typically <strong>excreted into the bile</strong> and helps to<strong> color the feces and urine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Unconjugated bilirubin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is<strong> not water-soluble</strong> and is<strong> carried in the bloodstream to the liver</strong>, where it is <strong>conjugated</strong>. It would<strong> not</strong> directly react with <strong>Ehrlich&rsquo;s solution</strong> to produce a <strong>purplish-brown color.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemosiderin</strong> - This is an <strong>iron-storage complex </strong>and is<strong> not </strong>typically detected in <strong>blood tests</strong> using <strong>Ehrlich&rsquo;s solution</strong>. It is usually found<strong> within tissues </strong>in conditions of <strong>iron overload.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture9.jpg\" style=\"height:703px; width:1000px\" /></span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan, 9/e: page 279, 350</span></strong></span></span></p>",
      "correct_choice_id": 30688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7682,
      "choices": [
        {
          "id": 30696,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gilbert Syndrome</span></span></span></p>"
        },
        {
          "id": 30697,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic jaundice</span></span></span></p>"
        },
        {
          "id": 30698,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive jaundice</span></span></span></p>"
        },
        {
          "id": 30699,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Viral hepatitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old boy is brought to the pediatric clinic with a history of yellowing skin and eyes. Laboratory tests reveal increased levels of serum bilirubin and bilirubin in the urine, but urobilinogen is not detected. Based on these findings, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q1600103",
      "question_audio": null,
      "question_video": null,
      "map_id": 29817,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive Jaundice</span></strong>&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; </span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugated bilirubin </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>increased in blood</strong> and so <strong>excreted in urine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If there is <strong>complete obstruction</strong>,<strong> UBG</strong> will be<strong> decreased in urine </strong>or even<strong> absent </strong>and the <strong>bile does not </strong>enter the<strong> intestine</strong> results in <strong>clay coloured stools.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gilbert Syndrome: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to defective <strong>uptake of bilirubin </strong>by the liver, leads to<strong> bilirubin level around 3 mg/dl </strong>with <strong>mild</strong> <strong>jaundice.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic jaundice:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Hemolytic disease of newborn and <strong>Hemolytic diseases of adults-</strong> <strong>increased </strong>blood <strong>unconjugated</strong> <strong>bilirubin</strong>, <strong>absence of bilirubinuria</strong> and <strong>increased excretion of UBG in urine</strong> and <strong>SBG in feces. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Viral hepatitis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common cause for <strong>hepatocellular jaundice (Hepatitis Viruses A, B, C, D or E) with elevated ALT and AST levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnostic approach</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture10.jpg\" style=\"height:567px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 332-334, DM Vasudevan 9/e: p 280-282</span></strong></span></span></p>",
      "correct_choice_id": 30698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}